vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Teledyne Technologies (TDY). Click either name above to swap in a different company.

Teledyne Technologies is the larger business by last-quarter revenue ($1.6B vs $829.0M, roughly 1.9× Acadia Healthcare Company, Inc.). Teledyne Technologies runs the higher net margin — 17.1% vs 0.5%, a 16.6% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 7.3%). Over the past eight quarters, Teledyne Technologies's revenue compounded faster (9.3% CAGR vs 2.0%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

Teledyne Technologies Incorporated is an American industrial conglomerate. It was founded in 1960, as Teledyne, Inc. by Henry Singleton and George Kozmetsky.

ACHC vs TDY — Head-to-Head

Bigger by revenue
TDY
TDY
1.9× larger
TDY
$1.6B
$829.0M
ACHC
Growing faster (revenue YoY)
ACHC
ACHC
+0.2% gap
ACHC
7.5%
7.3%
TDY
Higher net margin
TDY
TDY
16.6% more per $
TDY
17.1%
0.5%
ACHC
Faster 2-yr revenue CAGR
TDY
TDY
Annualised
TDY
9.3%
2.0%
ACHC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACHC
ACHC
TDY
TDY
Revenue
$829.0M
$1.6B
Net Profit
$4.5M
$275.6M
Gross Margin
42.9%
Operating Margin
20.4%
Net Margin
0.5%
17.1%
Revenue YoY
7.5%
7.3%
Net Profit YoY
-50.8%
38.8%
EPS (diluted)
$0.05
$5.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
TDY
TDY
Q1 26
$829.0M
Q4 25
$821.5M
$1.6B
Q3 25
$851.6M
$1.5B
Q2 25
$869.2M
$1.5B
Q1 25
$770.5M
$1.4B
Q4 24
$774.2M
$1.5B
Q3 24
$815.6M
$1.4B
Q2 24
$796.0M
$1.4B
Net Profit
ACHC
ACHC
TDY
TDY
Q1 26
$4.5M
Q4 25
$-1.2B
$275.6M
Q3 25
$36.2M
$220.7M
Q2 25
$30.1M
$209.9M
Q1 25
$8.4M
$188.6M
Q4 24
$32.6M
$198.5M
Q3 24
$68.1M
$262.0M
Q2 24
$78.5M
$180.2M
Gross Margin
ACHC
ACHC
TDY
TDY
Q1 26
Q4 25
42.9%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
42.7%
Q4 24
42.8%
Q3 24
42.9%
Q2 24
43.1%
Operating Margin
ACHC
ACHC
TDY
TDY
Q1 26
Q4 25
-142.4%
20.4%
Q3 25
4.7%
18.4%
Q2 25
5.8%
18.4%
Q1 25
1.7%
17.9%
Q4 24
4.9%
15.8%
Q3 24
12.1%
18.8%
Q2 24
13.4%
18.0%
Net Margin
ACHC
ACHC
TDY
TDY
Q1 26
0.5%
Q4 25
-143.3%
17.1%
Q3 25
4.3%
14.3%
Q2 25
3.5%
13.9%
Q1 25
1.1%
13.0%
Q4 24
4.2%
13.2%
Q3 24
8.4%
18.2%
Q2 24
9.9%
13.1%
EPS (diluted)
ACHC
ACHC
TDY
TDY
Q1 26
$0.05
Q4 25
$-12.98
$5.81
Q3 25
$0.40
$4.65
Q2 25
$0.33
$4.43
Q1 25
$0.09
$3.99
Q4 24
$0.36
$4.18
Q3 24
$0.74
$5.54
Q2 24
$0.85
$3.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
TDY
TDY
Cash + ST InvestmentsLiquidity on hand
$158.5M
$352.4M
Total DebtLower is stronger
$2.5B
$2.5B
Stockholders' EquityBook value
$2.0B
$10.5B
Total Assets
$5.5B
$15.3B
Debt / EquityLower = less leverage
1.29×
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
TDY
TDY
Q1 26
$158.5M
Q4 25
$133.2M
$352.4M
Q3 25
$118.7M
$528.6M
Q2 25
$131.4M
$310.9M
Q1 25
$91.2M
$461.5M
Q4 24
$76.3M
$649.8M
Q3 24
$82.1M
$561.0M
Q2 24
$77.2M
$443.2M
Total Debt
ACHC
ACHC
TDY
TDY
Q1 26
$2.5B
Q4 25
$2.5B
$2.5B
Q3 25
$2.3B
$2.5B
Q2 25
$2.3B
$2.6B
Q1 25
$2.2B
$3.0B
Q4 24
$2.0B
$2.6B
Q3 24
$1.9B
$2.8B
Q2 24
$1.8B
$2.8B
Stockholders' Equity
ACHC
ACHC
TDY
TDY
Q1 26
$2.0B
Q4 25
$1.9B
$10.5B
Q3 25
$3.1B
$10.6B
Q2 25
$3.1B
$10.4B
Q1 25
$3.0B
$9.9B
Q4 24
$3.1B
$9.5B
Q3 24
$3.0B
$9.6B
Q2 24
$3.0B
$9.3B
Total Assets
ACHC
ACHC
TDY
TDY
Q1 26
$5.5B
Q4 25
$5.5B
$15.3B
Q3 25
$6.4B
$15.4B
Q2 25
$6.3B
$15.1B
Q1 25
$6.1B
$15.0B
Q4 24
$6.0B
$14.2B
Q3 24
$5.9B
$14.5B
Q2 24
$5.7B
$14.2B
Debt / Equity
ACHC
ACHC
TDY
TDY
Q1 26
1.29×
Q4 25
1.28×
0.24×
Q3 25
0.74×
0.24×
Q2 25
0.74×
0.25×
Q1 25
0.72×
0.30×
Q4 24
0.64×
0.28×
Q3 24
0.62×
0.29×
Q2 24
0.62×
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
TDY
TDY
Operating Cash FlowLast quarter
$61.5M
$379.0M
Free Cash FlowOCF − Capex
$339.2M
FCF MarginFCF / Revenue
21.0%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
13.78×
1.38×
TTM Free Cash FlowTrailing 4 quarters
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
TDY
TDY
Q1 26
$61.5M
Q4 25
$-86.3M
$379.0M
Q3 25
$73.2M
$343.1M
Q2 25
$133.5M
$226.6M
Q1 25
$11.5M
$242.6M
Q4 24
$116.7M
$332.4M
Q3 24
$163.1M
$249.8M
Q2 24
$171.1M
$318.7M
Free Cash Flow
ACHC
ACHC
TDY
TDY
Q1 26
Q4 25
$-179.5M
$339.2M
Q3 25
$-63.0M
$313.9M
Q2 25
$-34.2M
$196.3M
Q1 25
$-163.2M
$224.6M
Q4 24
$-86.8M
$303.4M
Q3 24
$-27.1M
$228.7M
Q2 24
$16.9M
$301.0M
FCF Margin
ACHC
ACHC
TDY
TDY
Q1 26
Q4 25
-21.8%
21.0%
Q3 25
-7.4%
20.4%
Q2 25
-3.9%
13.0%
Q1 25
-21.2%
15.5%
Q4 24
-11.2%
20.2%
Q3 24
-3.3%
15.8%
Q2 24
2.1%
21.9%
Capex Intensity
ACHC
ACHC
TDY
TDY
Q1 26
Q4 25
11.3%
2.5%
Q3 25
16.0%
1.9%
Q2 25
19.3%
2.0%
Q1 25
22.7%
1.2%
Q4 24
26.3%
1.9%
Q3 24
23.3%
1.5%
Q2 24
19.4%
1.3%
Cash Conversion
ACHC
ACHC
TDY
TDY
Q1 26
13.78×
Q4 25
1.38×
Q3 25
2.02×
1.55×
Q2 25
4.43×
1.08×
Q1 25
1.37×
1.29×
Q4 24
3.58×
1.67×
Q3 24
2.39×
0.95×
Q2 24
2.18×
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$471.0M57%
Other$140.0M17%
Specialty Treatment Facilities$128.0M15%
Residential Treatment Facilities$90.0M11%

TDY
TDY

Commercial And Other$681.5M42%
Aerospace And Defense Electronics$275.9M17%
Marine Instrumentation$177.1M11%
United States Government$169.0M10%
Environmental Instrumentation$120.7M7%
Engineered Systems$103.3M6%
Test And Measurement Instrumentation$84.8M5%

Related Comparisons